Compare UTMD & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTMD | SPOK |
|---|---|---|
| Founded | 1978 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.5M | 230.7M |
| IPO Year | 1994 | 2004 |
| Metric | UTMD | SPOK |
|---|---|---|
| Price | $63.80 | $10.88 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 6.4K | ★ 156.9K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | 1.91% | ★ 11.31% |
| EPS Growth | N/A | ★ 2.74 |
| EPS | ★ 0.82 | 0.09 |
| Revenue | $38,520,000.00 | ★ $139,708,000.00 |
| Revenue This Year | N/A | $1.70 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $78.01 | $121.11 |
| Revenue Growth | N/A | ★ 1.49 |
| 52 Week Low | $52.00 | $9.95 |
| 52 Week High | $71.81 | $19.31 |
| Indicator | UTMD | SPOK |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 46.25 |
| Support Level | $60.23 | $10.87 |
| Resistance Level | $64.21 | $11.55 |
| Average True Range (ATR) | 1.42 | 0.36 |
| MACD | -0.36 | 0.03 |
| Stochastic Oscillator | 16.39 | 60.74 |
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.